There were four approaches to developing AD models: injection of Aβ (eight studies), transgenic AD (APP/PS1) (seven studies), streptozotocin (STZ) (three studies), and lipopolysaccharide (LPS) (one study). This evidence concerns the gene APP and Alzheimer disease.